Category Archives: Covid

Is Plan your vaccine legitimate Why do you have to pay a registration fee?

The US Food and Drug Administration has given Emergency Use Authorization for 2 immunizations for the counteraction of Covid infection 2019 (COVID-19).

This noteworthy logical accomplishment prepares to finish the pandemic, given that immunization take-up is adequate. While the specific extent is questionable, all things considered, over 75% of the US populace should be immunized for the country to get crowd immunity.1 Yet reviews have more than once shown that numerous individuals from the US public are hesitant to be inoculated, albeit this might change in the approaching months.2 subsequently, antibody take-up may miss the mark regarding important levels.

Various recommendations to work on intentional take-up of COVID-19 antibodies have progressed. These propositions are many times centered around cultivating public confidence in the antibody endorsement process, eliminating reasonable hindrances to immunization, and advancing antibody acknowledgment through local area commitment, the ID of confided in pioneers, and general wellbeing messaging.3 Recently, nonetheless, a few people from across the political range have proposed paying money impetuses for COVID-19 immunization.

In this Viewpoint, we depict elements of 2 installments for immunization recommendations that stand out from scholastics and legislators, frame a few significant protests, and keep up with that installment for inoculation is ethically suspect, probable pointless, and might be counterproductive.

Robert Litan, an alien senior individual at the Brookings Institution who served in the Clinton organization, has progressed the most hearty arrangement by recommending paying individuals for immunization, in a perfect world not exposed to taxes.4 Litan recognizes that there is no proof for his figure except for contends anything less is probably not going to do the trick. To keep away from holdouts, he prescribes the public authority commit front and center to not expanding installment.

To guarantee that enough individuals are inoculated, Litan recommends paying at first when the individual acknowledges immunization while molding installment of the excess on arriving at a public antibody take-up threshold.5 The goal of keeping the equilibrium is to produce a prevailing burden; those anxious to be paid will urge loved ones to be vaccinated. The assessed cost for this proposition would be roughly $275 billion, which Litan depicts as a “deal” contrasted and the financial impacts of the pandemic lingering.4 Litan’s proposition has been supported by Greg Mankiw, previous executive of the Council of Economic Advisors under President George W. Shrubbery, as well as Nobel Prize champ Paul Romer, business analyst Steven Levitt, and Wall Street Journal editorialist Jason Riley.6-8

COVID19

John Delaney, a previous representative from Maryland and 2020 Democratic official up-and-comer, has recommended paying each person in the US who gives confirmation of immunization $1500 by means of check or direct deposit.9 If each grown-up exploited this program, the assessed cost would be roughly $383 billion. Delaney battles that his arrangement is “worth the expense” since it would save lives, give “help to battling Americans [and]… speed up the returning of the economy.” Another 2020 official confident, Andrew Yang, tweeted his endorsement of Delaney’s arrangement.

Paying individuals to receive an immunization shot against COVID-19 may be a sensible strategy in the event that accomplishing group immunity was vital. However, installment for-immunization propositions are superfluous, yet tricky.

To start with, individuals have an ethical obligation to be immunized, including an obligation to advance their own wellbeing, an obligation to others to advance the local area advantage of immunization, and an obligation to society for people to do their reasonable part in ending the pandemic. Being immunized to get a $1000 or $1500 motivator denies the demonstration of moral importance. In any case, it is ethically proper to offer installment to individuals who are immunized to repay sensible immunization-related costs or as a type of remuneration for the time and exertion exhausted to become immunized, undifferentiated from the humble installment proposed to residents called for jury obligation. Such installments might try and be ethically basic assuming they are important to conquer obstructions to inoculation.

Second, paying a significant total as a motivating force to beat immunization reluctance and to advance immunization take-up is certainly not a judicious venture. Almost certainly, a greater part of the populace will be anxious to receive an immunization shot at the earliest opportunity considering the incredibly high and expanding number of SARS-CoV-2 diseases and COVID-19-related hospitalizations and passings. Additionally, a portion of the recorded hesitance may normally disperse as people notice others — confided in figures like Anthony Fauci, MD, broadly conspicuous lawmakers, and, surprisingly, their own clinicians — being immunized without unfavorable wellbeing impacts and as reports of immunization-related unfriendly impacts remain very uncommon. Likewise, it would be a significant waste to pay more to the large numbers of people in the US who are now profoundly energetic to get the immunization without expecting or looking for an impetus installment and furthermore to the people who require just consolation. There are opportunity costs related to involving cash for cash motivations. A portion of the proposition for paying individuals to receive an immunization shot would accompany significant expenses, potentially requiring a huge number of dollars; the cash would be all the more effectively spent tending to the pandemic in alternate ways.

Third, some could feel that a significant money-related motivator for inoculation is coercive. While this is a misguided judgment that mistakes a proposal for danger, there is a veritable moral worry about the impact of such motivation on choice-making.10 Offering installment as an impetus for COVID-19 immunization might be viewed as unjustifiably exploiting those US inhabitants who have lost positions, experienced food and lodging weakness, or slipped into destitution during the pandemic. Coronavirus has focused on the significant deficiencies of the social well-being net in the US. As people and families battle, certain individuals could feel they should acknowledge an immunization to, for instance, buy food or pay the lease. They could feel they must choose the option to be immunized for cash. It is profoundly hazardous that the public authority would offer money motivating forces to advance immunization when it has fizzled, in various occurrences all through this pandemic, to offer cash or different backings expected to guarantee the essential necessities of many individuals are being met. This worry might be especially articulated in the Black and Brown people groups, which have been excessively impacted by both the well-being and financial outcomes of the pandemic. Albeit these networks would be supposed to profit from elevated degrees of immunization, different strategies are more proper to advance this end than exchanging on monetary frailty.

Fourth, COVID-19 antibody aversion is established in worries, for example, the twist speed advancement and endorsement of immunizations, the politicization of the more extensive pandemic reaction, and even refusal that the pandemic is genuine. It is hazy that offering impetus installments would be able or will defeat anxieties like these. Rather, cash impetuses could sensibly be anticipated to elevate these worries or raise new ones, as offers of installment are frequently perceived to flag that a way of behaving is bothersome or risky.3 In an environment described by far-reaching doubt of government and penchant to support paranoid ideas, the people who are as of now COVID-19 immunization reluctant could see that the public authority might want to pay individuals to receive available immunizations assuming that the accessible immunizations were really protected and viable. Motivator installments could likewise stir up new feelings of dread and, unreasonably, increment protection from immunization.

A strategy of paying individuals for COVID-19 immunization ought to be embraced exclusively if all else fails on the off chance that willful immunization take-up demonstrates inadequate to advance group resistance within a sensible timeframe. Public subsidies would be better spent progressing other proof-based recommendations to increment intentional immunization take-up.

How the Federal Retail Pharmacy Program Works

The FRPP is intended to utilize the strength and aptitude of drug store accomplices to help quickly immunize the American public. Through the program, certain retail drug stores across the country are getting COVID-19 immunization supply straightforwardly from the national government.

As the stockpile of immunization has expanded, so has the number of retail stores giving COVID-19 inoculation. Drug store accomplices utilize this stockpile to immunize qualified people at no expense. The program depends on a coordinated effort with general wellbeing (CDC and state, nearby, and regional wellbeing divisions) to urge people to go to drug stores and receive an immunization shot.

Local area outreach stays basic to teaching individuals about the significance of inoculation and where immunizations are accessible close by. For more data, see 12 COVID-19 Vaccination Strategies for Your Community.

COVID-19 Vaccine Eligibility and Availability

Everybody 5 years old and more established is presently qualified to get a COVID-19 immunization.
You can visit Vaccines.gov; text your postal district or actually look at your state wellbeing division site. Visit How Do I Get a COVID-19 Vaccine to find out more.
People keen on receiving an immunization shot at their neighborhood drug store ought to look at the drug store’s site to find if COVID-19 immunization is accessible. Most drug store areas are currently offering stroll-in immunization arrangements as supply permits.

Will I have to pay for the vaccine?

No. The immunization is being given for nothing to all people by the central government. Assuming you have protection, it will be charged at no expense to you. Be that as it may, you needn’t bother with to be guaranteed to get the immunization. You won’t ever be requested a charge card number to make an arrangement.

What is the difference between an additional dose and a booster shot of the COVID-19 vaccine?

Additional dose

An extra portion is prescribed for certain people to give added security against serious and hazardous COVID-19 sickness. At times individuals, including the people who are decent to seriously immunocompromised, don’t assemble sufficient assurance against COVID-19 from their underlying two dosages of an mRNA immunization, which incorporates Pfizer-BioNTech (Comirnaty) and Moderna (Spikevax) antibodies. An extra portion, given no less than 28 days after the fruition of the underlying two-portion series, is displayed to work on a resistant reaction in those people.

COVID

Booster Shot

A promoter shot is suggested for completely inoculated people 5 and more seasoned. Proof recommends that the resistant reaction to COVID-19 immunizations probably diminishes over the long haul, and a supporter shot offers further developed insurance against COVID-19.

Whether you are qualified to have a promoter chance relies upon which immunization you at first got and how quite a while in the past you got it.

Whats was the first virus 🦠 to mankind?

Abstract

In December 2019, a novel coronavirus outbreak was first reported in Wuhan, Hubei Province, China. It has now been confirmed on six continents and in over 100 nations as of this writing. New knowledge is produced on a regular basis as the world’s health systems devote resources to learning about, treating, and avoiding infections in humans. We will first provide some background on coronaviruses to put this disease epidemic in context, then explore global health security and pandemic response preparation in this two-part article series. Second, we’ll provide advice on prevention and planning in the office and at home from the most reliable sources.

A plaque honoring two partners in the discovery of a mosquito vector for yellow fever virus can be found on the wall of a Columbia University Medical Center building just across the street from my lab.

The Plaque Reads:

Graduates of Columbia University College of Physicians and Surgeons, class of 1892, Aristides Agramonte and Jesse William Lazear. U.S. Army Acting Assistant Surgeons Drs. Walter Reed and James Carroll are members of the United States Yellow Fever Commission. They assisted in the eradication of a man-made plague by devotion and self-sacrifice.

virus

Yellow fever, which has been seen in tropical areas since the 15th century, has caused devastating epidemics with high mortality rates. The disease can be minor, with symptoms such as fever and nausea, but it can also be severe, with catastrophic organ failure. The name of the disease comes from the yellowing of the skin (jaundice) caused by liver damage. For most of its history, nothing was known about the spread of yellow fever.

What are coronaviruses?

Coronaviruses are a broad family of zoonotic viruses that can cause everything from a simple cold to severe respiratory illnesses. These viruses are zoonotic, which means they can spread from animals to humans. Several coronaviruses have been identified as circulating in various animal species but have not yet infected humans. The COVID-19 strain is the most recent to infect humans.

COVID-19 infection symptoms are comparable to a cold and include a dry cough, fever, shortness of breath, and difficulty breathing. Infection can lead to pneumonia, severe acute respiratory syndrome, kidney failure, and even death in the most serious cases.

The COVID-19 disease is spread from one individual to others by means of beads delivered from the respiratory arrangement of contaminated individuals, frequently during hacking or sniffling. As per current information, time from openness to the beginning of side effects is for the most part somewhere in the range of two and 14 days, with a normal of five days.

Recent coronavirus outbreak history

Two other late Covid episodes have been capable. Center East Respiratory Syndrome (MERS-CoV) of 2012 was found to communicate from dromedary camels to people. In 2002, Severe Acute Respiratory Syndrome (SARS-CoV) was found to communicate from civet felines to people.

virus 1

In spite of the fact that COVID-19 has previously shown a few likenesses to ongoing Covid episodes, there are contrasts and we will learn substantially more as we manage this one. SARS cases added up to 8,098 with a casualty pace of 11% as detailed in 17 nations, with most of the cases happening in a southern central area of China and Hong Kong. The casualty rate was exceptionally reliant upon the age of the patient with those under 24 to the least extent liable to pass on (one percent) and those north of 65 probably going to kick the bucket (55%). No cases have been accounted for overall since.

Global Health Security

An extensive analysis of health security and response capacities across 195 countries was conducted by an international team of experts. 5 The project’s goals were to assess the risks of infectious disease outbreaks that might result in global epidemics and pandemics and to gauge each country’s capacity for response. The GHS Index was expected to have measurable effects on national health security and increase global readiness.

The GHS Index assessed variables in six major categories:

Prevention: Stopping the spread or appearance of pathogens.

COVID

Early detection and reporting for epidemics that may be of concern on a global scale.

Rapid Response: Quick response to an outbreak and mitigation of its spread.

Health System: A complete and effective health system that can treat patients and safeguard medical professionals.

Adherence to international standards and commitments to strengthening national capacity are examples of compliance with international standards.
Risk Environment: General risk environment and biological threat susceptibility of the nation.

Pfizer wants to offer a booster dose of the vaccine to 5-11 year olds

Pharmaceutical company Pfizer said on Thursday that it wanted to offer its booster shots of the COVID-19 vaccine to healthy children of primary school age.

US health officials are already urging everyone 12 and older to get a booster dose for better protection against new variants – and recently offered the option of a second booster for people 50 and older.

Pfizer now says new data indicates that healthy children aged 5 to 11 could benefit from another child-dose vaccine.

boostervaccine1

In a small study, 140 young people who had already received two injections received a booster six months later, and the researchers found that this additional dose generally increased their immune response. But a closer examination of 30 of the children found a 36-fold increase in anti-virus antibodies, levels high enough to fight off the highly contagious Omicron variant, Pfizer and partner BioNTech said in a press release.

The BA.2 sub-variant in the sights

Pfizer tested the booster dose for children when Omicron was booming this winter. While COVID-19 cases are now at much lower levels in the United States, in recent weeks an even more contagious version of Omicron, called BA.2, has become the dominant type locally and globally.

In the coming days, the companies plan to ask the U.S. Food and Drug Administration to authorize a recall for healthy children ages 5 to 11. They also plan to share the data with regulators in Europe and elsewhere.

booster vaccine

Vaccines are generally less effective against the Omicron variant than earlier versions of the coronavirus – but they still offer strong protection against severe forms of the disease. Although COVID-19 is a greater threat to adults, young people can still become seriously ill. But regulators will have to decide if healthy primary-aged children really need a booster, and if so, when.

Pfizer’s vaccine is the only one available for children in the United States. Children 5 to 11 years of age receive one-third of the dose given to 12 years and older. Just over a quarter of young people have received two doses since the vaccine was made available to them in November, shortly before Omicron arrived.

The United States has not yet authorized the vaccination of children under 5 years of age. But some children aged 5 to 11 – those with severely weakened immune systems – are already supposed to receive three doses, to enable the best possible immune response for this high-risk group.

The Virus Sets Off Alerts About The Importance Of Workers

Tipping points are often more difficult to identify as they occur than afterwards. But that hasn’t stopped people from wondering if there is lasting change in the job market. After 40 years in which capital has had the upper hand, is the power of the workers increasing?

If so, it will mark a profound economic reversal for much of the rich world. Since 1985, union membership has been reduced by half on average in the Organization for Economic Cooperation and Development (OECD) countries , while the coverage of collective agreements signed at the national, sectoral or company levels decreased by one third. At the same time, the workers take a smaller slice of the pie. The growth of the real average wage has not kept pace with the growth of productivity on average of the 24 countries of the organization during the last two decades.

But the pandemic precipitated a worker shortage in many countries that caught employers off guard. Migrants returned to their home countries, older people retired earlier, and health or childcare problems led others to leave the labor market.

Workers try to take advantage of its sudden scarcity value. In the United States , unionized workers launched a series of strikes, from John Deere to Kellogg . They also tried to organize in low-paid sectors with no history of union presence, from Starbucks to Amazon. In the UK, the proportion of employees affiliated with unions began to rise after decades of decline. They also find new ways to fight for what they want. Organize, a UK-based workers’ advocacy campaign platform, now has over a million members after rapid growth during the pandemic.

Policy makers in some countries are trying to help tip the balance. Joe Biden, president of the United States, promised to be “the most pro-union president ever seen” and wants to pass legislation that makes organizing easier. The European Commission published draft legislation that it says will end companies in the chambas economy that misclassify people as “self-employed” to avoid giving them rights and protections as workers.

Demographic factors, which are evolving little by little, can also contribute. Some economists believe that the global glut of workers in recent decades is about to end as population growth slows and the world’s share of working-age people begins to shrink. This can drive salary growth by making staff harder to find.

On the other hand, workers will see that their moment of advantage is fleeting. More jobs and tasks are likely to be susceptible to automation as both robotics and artificial intelligence improve. The rise of telecommuting and crowd platforms, which divide jobs into small tasks, may lead to a new wave of globalization affecting administrative staff in the industrialized world.

Regardless of whether the balance of power between capital and labor has changed forever, the pandemic has been instructive for both parties. Employers discovered that staff availability is not a fact, but rather a business risk that needs to be mitigated. Many pay more attention to hiring and retention, and not just in the professional world. And a new generation of workers, from people who replenish products on shelves to delivery men, have learned how essential they really are.

Even With The New Omicron Variant, Vaccines Are Still The Best Solution And These Are The Reasons

Doctors still don’t know exactly how well current covid-19 vaccines protect people against the new omicron variant, already in the United States. But what they do know is that people shouldn’t wait to get a vaccine or a booster dose.

“Getting maximum protection is now more important than ever, and not just by omicron,” US Health Director Dr. Vivek Murthy told CNN on Tuesday.

More than 40% of the US population still needs the full vaccination schedule, according to the US Centers for Disease Control and Prevention (CDC).

And only 23% of fully vaccinated adults in the US have received a booster dose.

On Monday, following news about the omicron variant, the CDC recommended that everyone 18 and older receive a booster dose.

Although it takes scientists a couple of weeks to better understand the efficacy of current vaccines against the new variant, public health experts say it shouldn’t be expected.

While the news focuses on the new omicron variant, it is the highly transmissible delta variant that remains a major problem in the US Cases have yet to return to lows this summer.

On average, the United States records more than 70,000 new COVID-19 cases and 730 deaths per day, according to Johns Hopkins University.

Booster doses work well against the delta variant. A study published Tuesday found that a booster dose of the Pfizer vaccine reduces the risk of COVID-19 infection by 80% or more, above the protection offered by the first two doses.

It’s coronavirus season

Winter is here. It is a season when people spend more time indoors, where the virus spreads more easily. A study conducted in Japan last year found that the virus was 19 times more likely to spread indoors than outdoors. Virus particles also stay longer in drier winter weather, and our noses get dry, potentially leaving them more vulnerable to infection.

Families also travel and gather during vacations, increasing the risk of exposure.

Vaccines should offer some protection regardless of variant

While drug companies are still testing their vaccines to see how well they work against omicron, there is at least some indication that current vaccines should protect people regardless of the variant, according to Dr. Anthony Fauci, director of the National Institute of Allergy and Allergy. Infectious diseases.

The vaccines produce a strong and broad immune response that provides an additional cushion of protection, he said.

“Our experience with variants such as delta is that, although the vaccine is not specifically targeted at that variant when you get a high enough level of the immune response, you get spillover protection, even against a variant that the vaccine does not. it was specifically targeted, “Fauci said at a briefing at the White House on Wednesday.

“That’s why we think that although we don’t have a lot of data on this, there are many reasons to believe that the kind of boost that you get with the booster dose would be helpful, at least to prevent severe disease from a variant. like omicron “.

The many mutations in the new variant make it what Dr. Francis Collins, director of the National Institutes of Health, called “a somewhat different animal” on Tuesday. That can lower the degree of protection; however, the body’s immune system is “smart,” especially when vaccinated, he said.

“Not only does it increase the level of antibodies, but it increases the breadth of the coverage that they have of spike proteins that their system has not even seen before, but is now ready,” Collins said. “It is that phenomenon that I think is going to help us here.”

The danger of producing more mutations

Getting vaccinated isn’t just about protecting yourself, experts say, it’s about protecting others as well. The more people that are infected, the more likely it is that the variants will evolve in their bodies.

People who are not vaccinated often take longer to fight infections and that gives the virus a better chance to change.

“The virus mutates when people become infected. It does not mutate in the air, so even if you were infected and it was fine, guess what?” Said Dr. Jorge E. Rodríguez, an internal medicine specialist who performs internships. in Newport Beach, California, and is a medical analyst for CNN. “You may have contributed to mutations that will be stronger, so there is no good infection, even if you survived it with minimal symptoms.”

Omicron Variant

Treatments may not work as well

If you do get sick, your treatment options may be more limited with the omicron variant.

Due to multiple mutations in the spike protein that Regeneron’s monoclonal therapies target, the company is investigating whether the treatments will continue to work as well.

“Further analysis is underway to confirm and quantify this potential impact using the actual omicron variant sequence,” Regeneron said Tuesday. He added that the mutations seen in the omicron variant indicate that its treatment with monoclonal antibodies, which activate the immune system, might not work as well against infections caused by the new variant.

Gilead, the maker of redelivering, the only antiviral that has been approved for the treatment of COVID-19, said there is no indication that the mutations seen in the omicron variant will limit the drug’s effects, although the company is running tests to make sure.

Omicron might not be dominant

Scientists don’t yet know if the omicron variant will become the dominant strain as delta did. Dr. Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine, thinks it’s unlikely.

“When you look at the sequence of the virus in terms of its transmissibility, it looks a lot like the alpha variant that emerged in the UK and arrived in the US at the beginning of the year, which was more transmissible than the original lineage, but not more transmissible than delta, “Hotez told CNN on Tuesday.

“On that basis, I don’t think omicron is necessarily going to outperform delta.”

Even if it is not dominant, omicron could become a problem for people who have been infected and recovered and not vaccinated, he said.

The new vaccine would take time

If for some reason, current vaccines don’t provide as much protection, there is a backup plan. But it will take time.

Pfizer and Moderna said they are already testing a specific vaccine for Omicron just in case, even though they are still trying to figure out how current vaccines against the variant work.

“If we need it, we won’t waste time,” Pfizer CEO Albert Bourla told CNN on Monday. When the beta and delta variants began to circulate, Bourla said the company also made vaccines specifically for those variants, but that they were not necessary. The original vaccines offered good protection. Bourla believes the same will happen with omicron.

“I doubt the results will make us realize that we are not protected at all,” Bourla said.

Moderna’s chief medical officer, Dr. Paul Burton, said he is concerned about this “new twist in the fight against covid,” but still believes that his company’s vaccine provides protection.

“I think we have to assume that it is very good to have some vaccine, even against a very altered and highly dangerous variant,” he said.

And if a special vaccine is needed, it will take about 100 days for it to reach people’s arms. The Biden administration said it is working closely with manufacturers to make sure new vaccines if needed, are quickly accessible.

In the meantime, getting a vaccine or a booster dose now, rather than waiting, is the best course of action.

“The bottom line is that if you want to maximize your protection against all variants, getting a booster dose is the way to go,” Murthy said.

Risks Of Dying From Covid-19 Increases In Unvaccinated People

The United States authorities closely follow the progress of the pandemic in their territory and constantly evaluate the effects that vaccination is having on the population. During this follow-up, it was found that unvaccinated people have a greater chance of presenting a serious disease and dying, as other studies have confirmed.

In the study, the CDC examined the effectiveness of vaccines against the most severe consequences of the disease. For reasons that are not entirely clear, data from one of the studies suggest that Moderna’s vaccine offered a slightly higher level of protection in the period where the delta variant was prevalent.

The study comes a day after President Joe Biden announced a strong new immunization plan that includes requirements for companies to employ more than 100 workers to be vaccinated or tested weekly.

The first study examined hundreds of thousands of cases in 13 United States jurisdictions between April 9 and June 19, before delta was dominant, and compared them with data collected between June 20 and July 17. From one period to the next, risk of people vaccinated from being infected with covid increased slightly: they went from being 11.1 times less likely to be infected compared to those not vaccinated, to 4.6 times less.

Protection against the risk of hospitalization and death remained more stable but fell more among those over 65 years concerning the younger groups.

The CDC and the Food and Drug Administration (FDA) are evaluating the need for booster vaccines, and older people are likely to be among the first to receive them when the Biden administration begins distributing them later this month.

One of the studies, which evaluated the effectiveness of the vaccine between June and August in more than 400 hospitals, emergency departments, and urgent care clinics, examined the effectiveness of each laboratory.

Moderna’s vaccine was most effective against hospitalization with 95%, then Pfizer with 80%, and finally Johnson & Johnson with 60%.

The CDC also warned in recent days that daily deaths from coronavirus increased in the country by 131% in the last month. At the moment, more than 640,000 people have died in the United States from the pandemic.

The delta variant is already the main responsible for the new hospital admissions, with 89,916 patients on September 2, figures that had not been seen since January 30 when 89,657 people had to be hospitalized. In some states, such as Georgia, Kentucky, and Hawaii, there are no clearances in intensive care units.

The CDC has also reported an increase in income for children and adolescents. The main person in charge of the fight against the coronavirus in the United States, Anthony Fauci, points out that there is still no data to determine that this variant occurs more aggressively among minors, who can access the Pfizer vaccine for 12 years.

Moderna: FDA Postpones Decision on Adolescent Vaccine, Why?

A Chester County, Pennsylvania Department of Health worker filling a syringe with Moderna’s COVID-19 vaccine at the Chester County Government Services Center in West Chester, Pennsylvania. 
(ASSOCIATED PRESS)
Regulators in the United States are delaying their decision on the application of Moderna’s vaccine against COVID-19 in children aged 12 to 17 years while they study an unusual risk of cardiac inflammation that it can cause, the pharmaceutical company reported.

The US Food and Drug Administration (FDA) told the company that its review could take until January, Moderna said.

The company also indicated that it will delay the submission of an application for authorization for emergency use of a lower dose of the vaccine for children 6 to 11 years old.

Inflammation of the heart is an extremely rare risk in both Moderna’s and Pfizer’s vaccines, and is seen most often in young men and boys.

It is difficult to detect the problem in clinical trials. And public health authorities have repeatedly stressed that COVID-19 itself can cause inflammation at a higher incidence than rare cases caused by the vaccine.

In the United States, Moderna’s vaccine is licensed for use in those 18 years of age and older.

Moderna pointed out that more than 1.5 million adolescents worldwide have received the vaccine and that the number of reports of heart inflammation “does not suggest an increased risk” for those under 18 years of age.

In the United States, children ages 12 to 17 can receive the vaccine produced by Pfizer and its partner BioNTech.

The FDA took action last week to allow the use of Pfizer’s vaccine in children ages 5 to 11. The US Centers for Disease Control and Prevention (CDC) will debate the issue this week.

Moderna has also been testing two injections, one month apart, for children ages 6 to 11, with half the dose for adults.

Older Adults Are Especially Vulnerable To Covid 19

As the US tries to control COVID-19 ahead of a possible winter rebound, health experts are encouraging vulnerable people to get a booster dose of the vaccine. So far, about 15% of the elderly have.

In total, about 10.7 million people received an additional booster dose and more than half were people over 65, according to data from the U.S. Centers for Disease Control and Prevention (CDC, for its acronym in English).

The U.S. Food and Drug Administration (FDA) has recommended booster doses for the most vulnerable people, such as those over 65, those at high risk for serious illness, and those at high risk of severe disease. who live or work in high-risk environments.

Last month, Pfizer received an emergency use authorization for a booster dose for certain people who have been at least six months after the initial two doses. And the nation’s health advisers are now studying emergency approval for the Moderna and Johnson & Johnson reinforcements.

“(Extremely vulnerable people) are recommended a booster shot,” said Dr. Leana Wen, CNN medical analyst. “But even with a booster, they may not prevent serious outcomes and this is why you have to get vaccinated.”

Strong immune protection through vaccination is the best way to avoid infection and control the pandemic. But the effort to increase protection with boosters comes as the nation continues to struggle to attract a substantial percentage of the population to be fully vaccinated.

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said the vast majority of Americans will need to get vaccinated to control the spread of the virus, but that number now only stands at around 57% of the total population…

What caused the death of Colin Powell from complications of covid-19

The importance of vaccination was emphasized on Monday after news broke that former Secretary of State Colin Powell had died of complications from Covid-19.

Powell, 84, suffered from multiple myeloma, a plasma cell cancer that suppresses the body’s immune response, as well as Parkinson’s, Peggy Cifrino, Powell’s longtime chief of staff, told CNN. He was fully vaccinated and was scheduled to receive a booster dose this week, but his health status put him at higher risk.

Powell’s death should not be taken as a sign that vaccines are insufficient, Wen said, but as proof that more people need to be vaccinated to protect the elderly and medically fragile.

“Yes, the vaccine protects you, but it protects you even more if everyone around you is vaccinated,” Wen said. “We vaccinate as healthy people in part to protect the most vulnerable among us.”

And post-vaccination infection cases, like Powell’s, are rare but expected, as no vaccine is 100% effective.

As of October 12, a total of 7,178 deaths have been reported to the CDC in people with post-vaccination infection. By then, more than 187 million people in the US were fully vaccinated. That means that one in 26,000 fully vaccinated people has died of COVID-19 or 0.004%. Of those cases that resulted in death, 85% were among people 65 and older and 57% were among men, according to the CDC.

For those who wish to boost their immune response with a booster dose, mixing and matching vaccines may soon be an option.

People familiar with FDA planning told The New York Times that the agency is planning to allow people to receive a different Covid-19 booster vaccine than the one they initially received.

According to this medium, the FDA could point out that it is preferable to receive the same vaccine as a booster, but would not recommend one injection over the other.

New Mexico, under crisis care standards

Hospitalizations for covid-19 have decreased nationally, but some regions remain overwhelmed.

Seven states have less than 15% of beds available in the ICU, according to data from the Department of Health and Human Services. Those states are Alabama, Georgia, Idaho, New Mexico, North Dakota, Oklahoma, and Texas.

In New Mexico, the health department had to enact crisis management standards.

According to a press release from the New Mexico Department of Health (NMDH), hospitals will now have to temporarily suspend medically unnecessary procedures before deciding who should receive care.

“Due to COVID, New Mexico’s hospitals and health centers endured an unmanageable burden. Today, the state is offering clarity and support as providers seek to make difficult decisions about how to allocate scarce – and precious – healthcare resources,” said DOH Acting Secretary David R. Scrase, MD “The goals, as always, remain the same: to save as many New Mexico lives as possible, and to help sustain the health care providers who have sustained our communities throughout this pandemic. ”

On Monday, state health authorities announced 1,895 new cases, bringing the total number of cases in the state since the pandemic began to 265,632. There are currently 300 patients in the hospital who are being treated for covid-19.

Immunization mandates are implemented for police departments

To increase vaccinations (and in turn control the spread) many employers have begun to impose vaccinations on their workers.

In Washington state, members of the Seattle police department had until the end of Monday to get vaccinated or receive an exemption.

As of Monday night, 91% of the police force had shown proof of vaccination and 7% presented exemptions, leaving only 2% of the department that had not presented their vaccination status.

“For officers who have not turned in any verification documents by midnight today (for this Monday), they should not report to work tomorrow and the city and department will begin the dismissal process for not following the guidelines of the vaccine mandate. “SPD spokesman Randy Huserik told CNN.

The state has also implemented the vaccination mandate for state employees, and some are choosing to leave their jobs rather than comply.

In videos uploaded by a conservative radio host on YouTube in the Seattle area, two state troopers were among state employees who cited Governor Jay Inslee’s vaccination mandate as the reason for their discharge.

One of them, Sergeant Richard Thompson, a 17-year veteran, can be seen inside his patrol car signing off from his duties and saying: “Due to my personal decision to take a moral stance against, for freedom medical and personal choice, today I will sign my discharge from service for the last time. ”

On the other hand, Washington State University announced that head soccer coach Nick Rolovich, as well as assistant soccer, coaches Ricky Logo, John Richardson, Craig Stutzmann, and Mark Weber, can no longer train for failing to comply with the vaccination mandate. of the state.

Colin Powell dies of complications from COVID-19

Colin Powell, the US Secretary of State, watches as President Bush delivers a speech at the State Department in Washington on February 15, 2001. Powell died of complications from COVID-19, his family said!
Colin Powell, who worked with Democratic and Republican US presidents on war and peace but whose fine reputation forever deteriorated when he appeared before the United Nations and made incorrect claims to justify the US war in Iraq, died Monday of complications. by COVID-19. He was 84 years old.

Powell, a veteran of the Vietnam War, rose to the rank of four-star general and in 1989 became the first black person to chair the Joint Chiefs of Staff. In that role, he oversaw the U.S. invasion of Panama and later Kuwait to drive out the Iraqi army in 1991.

But his legacy was ruined when, in 2003, he appeared before the UN Security Council in his role as secretary of state and defended the US war against Iraq at a time of enormous international skepticism. He cited misinformation that former Iraqi President Saddam Hussein had hidden weapons of mass destruction. Baghdad’s claims that they did not have such weapons represent a “web of lies,” Powell told the body at the time.

In announcing Powell’s death on social media, his family said he was fully vaccinated against the coronavirus.

“We have lost an extraordinary and loving husband, father and grandfather, and a great American,” the family said. Powell was being treated at Walter Reed National Medical Center in Bethesda, Maryland.

Peggy Cifrino, a longtime assistant to Powell, ‘said the former official had been treated for multiple myeloma, a blood cancer, for the past several years. Powell’s family’s post on social media did not indicate if Powell had any pre-existing illnesses.

Multiple myeloma affects the body’s ability to fight infection, and studies have shown that these cancer patients do not get as much protection from COVID-19 vaccines as people without the disease.

Powell was the first American official to publicly blame Osama bin Laden’s al Qaeda network for the terrorist attacks of September 11, 2001, and took a whirlwind trip to Pakistan in October of that same year to demand then-Pakistani President Pervez Musharraf. to cooperate with the United States in operations against the group established in Afghanistan, which also had a presence in Pakistan – where bin Laden was later killed.

Former President George W. Bush said Monday that he and his wife Laura Bush were “deeply saddened” by Powell’s death.

“He was a great public servant” and “widely respected at home and abroad,” Bush said. “And most importantly, Colin was a family man and a friend. Laura and I send Alma and her children our condolences as they remember the life of a great man ”.

Defense Secretary Lloyd Austin, a retired US Army general, said the news of Powell’s death left “a hole in my heart.”

Fauci: Another Rise In Covid-19 Can Be Prevented

The optimistic turn in the number of COVID-19 cases, hospitalizations, and deaths could end in another spike in infections, Dr. Anthony Fauci said Sunday. But the US could still prevent that increase with higher vaccination rates.

“If we do not do very well in that regard, there is always the danger that there is enough virus circulating that can delay the decrease in the number of cases, and when that happens, as we have seen in the past, with other waves through which we have passed, there is a danger of a resurgence, “Fauci, director of the National Institute of Allergy and Infectious Diseases and chief medical adviser to President Joe Biden, said on Fox News Sunday.

Although cases remain high, averaging about 85,000 new infections a day through Sunday, they have dropped by more than 8,000 from the previous week, according to data from Johns Hopkins University. Deaths have dropped an average of more than 200 a day since the beginning of the month.

However, progress in numbers continues to be threatened by low vaccination rates. As of Sunday, 57% of the total population was fully vaccinated against the virus, according to the US Centers for Disease Control and Prevention ( CDC ).

And while health experts don’t know exactly what proportion of the population needs to be protected to control the spread of the virus, Fauci has said that a vast majority will need to be vaccinated.

The good news is that Fauci doesn’t think another spike in cases is inevitable.

“It will be within our ability to prevent that from happening,” Fauci said. “The degree to which we continue to go down that slope will depend on how well we do it vaccinating more people.”

Vaccine mandates backfire, says the governor

Health experts have pointed to vaccine mandates as a key tool in reducing cases and easing hospital stress, but some officials strongly oppose the measures.

Fauci has been an advocate for the mandates, saying the data shows they work to get more people vaccinated. And while it would be preferable to convince people to choose to get vaccinated, that’s not always feasible, he said.

“I think when you are in a public health crisis, sometimes unusual situations require unusual actions,” Fauci told Fox News.

But Arkansas Governor Asa Hutchinson said Sunday that he believes both federal and state mandates are counterproductive to increasing vaccination rates.

Hutchinson told NBC News that he believes mixed messages at the highest levels of government have “slowed down acceptance of the vaccine and increased resistance.”

“I would like to see us arrive, without the battle of the mandate, let’s just encourage the acceptance of the vaccine, build trust in it, and that is the direction we must take,” said the governor.

When asked specifically about the success of the Tyson Foods and Walmart vaccine mandates in Arkansas, the governor said this “absolutely” proves the mandates work.

“So yes, there is effectiveness there. So let me clarify that when I say that I don’t think we should get into mandates, I mean government mandates, be it a federal government mandate or a state government mandate,” he said.

Hutchinson noted that employers must navigate a nuanced reality and on the ground of some employees wanting a mandatory vaccine work environment to feel safe, while others do not. Hutchinson said that based on that situation, the choice of whether or not to order vaccination should be left to employers.

Emergency and Urgent Services in Minnesota Suspended Due to Nurse Strike

In many places, the burden of hospital strain from COVID-19 has fallen on nurses, and a strike in Minnesota has affected services.

Urgent and emergency care services have been temporarily suspended at Abbott Northwestern WestHealth in Plymouth, Minnesota, as about 50 nurses from the Minnesota Nurses Association (MNA) decided to strike, according to a statement from Allina Health.

Nurses are on strike to seek “a contract that provides fair wages and benefits to nurses on the front lines of the covid-19 pandemic,” the MNA said in a statement Thursday.

“MNA nurses have been negotiating a new contract for months, but Allina has refused to accept fair pay for vacation work or adequate benefits,” the MNA said in the statement. “Compensating nurses fairly for work on holidays is especially critical because understaffing from Allina and other hospital systems have required nurses to work longer days and hours, including overtime and holidays while continuing on the front lines of the covid-19 pandemic “.

The shutdown began Sunday morning and will last until 7:00 am local time on Wednesday, according to the statement.

“Allina Health and Abbott Northwestern WestHealth have negotiated with MNA 7 times. A contractual agreement was previously reached and was unanimously recommended by the union’s bargaining team. Unfortunately, MNA was unable to finalize that agreement,” says the Allina Health statement. “Throughout the negotiations, we have consistently offered proposals that demonstrate our commitment to our female employees, including an immediate pay increase to align salaries with other metropolitan hospitals and agreement with some of the union’s other priority issues.”